day 1.5 times (OR = 1.49, 95% CI [1.07-2.08]) are
more likely to have anxiety (p <0.05).
This study, however, does not match the
study by Khademalhosseini in 2015 in Iran against
1020 high school adolescents where there is no
significant relationship between smokers and
anxiety. In addition, the findings of Lee et al in 2017
in the United States with interesting findings suggest
that mild smokers (less than 1-5 cigarettes a day) but
very depressed/depressed have a 5.8 times greater
risk of having anxiety disorders Thorough compared
to individuals who do not smoke and have mild
symptoms of depression. Also, multiple stroke but
highly depressed smokers have a 3.8 times greater
risk for having an overall anxiety disorder,
compared to people who smoked less than half a
pack a day and had low symptoms of depression.
Symptoms of depression seem to have a stronger
relationship with a complete anxiety disorder than
smoking.
Recent conclusions in terms of cigarette linkage
with anxiety can be seen from a literature study by
Fluharty et al in 2017 in the UK where from 148
studies categorized as: onset of smoking, smoking
status, heavy smoking, tobacco dependence and
smoking trajectory. The results for each category
vary substantially, with positive associative evidence
in both directions (smoking with later mental health
effects and mental health leads to later smoking
behavior). Overall, nearly half of the studies
reported that baseline anxiety was associated with
several types of smoking behavior, while more than
one-third found evidence that smoking exposure was
associated with anxiety that would subsequently
emerge. However, there are several studies that
directly support the two-way model of smoking and
anxiety can occur mutually. While this incidence
could be explained by the fact that the impact given
to smokers has the effect of being given
psychostimulants. Acute nicotine exposure, whether
obtained by smoking or intravenous infusion of
nicotine, has an effect on elevating the amount of
cortisol in the human body and animals. Long-term
smoking can cause persistent dysregulation of
hormonal regulation. Hypertensive patients also
experience increased sympathetic tone, where can
increase the intensity of anxiety symptoms in
patients.
REFERENCES
Aditama TY. Final Report Global Youth Tobacco
Survey Jakarta- Bekasi- Medan-Indonesia. 2003-
2004: 17- 18.
Badan penelitian dan Pengembangan Kesehatan
Kementrian Kesehatan RI. Penggunaan
Tembakau. Riset Kesehatan Dasar (Riskesdas).
2010; 399.
Baron, J. A., Comi, R. J., Cryns, V., Brinck-Johnsen,
T., & Mercer, N. G. 2017. The effect of cigarette
smoking on adrenal cortical hormones. Journal
of Pharmacology and Experimental
Therapeutics, 272, 151–155
Caggiula, A. R., Epstein, L. H., Antelman, S. M.,
Saylor, S. S., Perkins, K. A., et al. 2016.
Conditioned tolerance to the anorectic and
corticosterone-elevating effects of nicotine.
Pharmacology, Biochemistry and Behavior, 40,
53–59.
Hughes JR. Tobacco withdrawal in self-quitters.
Journal of Consulting and Clinical Psychology.
1992; 60(5): 689–697.
Hughes JR. Pharmacotherapy for smoking cessation:
Unvalidated assumptions, anomalies, and
suggestions for future study. Journal of
Consulting and Clinical Psychology. 1993;
61(5): 751–760.
Hughes JR, Hatsukami DK, Mitchell JE, &
Dahlgren LA. Prevalence of smoking among
psychiatric outpatients. American Journal of
Psychiatry. 1986; 143: 993–997.
Johnson JG. Associaion cigarette smoking and
anxiety disorders during andolescense and early
adulthood. The Journal American Medical
Association. 2000; 284: 2348-2351.
Kamaludin A. Pemantauan dopamin transporter
sebagai biomarker dalam keberhasilan berhenti
merokok. Jakarta: Indonesian Psychiatric
Quarterly 2011, no. 4: p. 77- 89.
McDowell I. Measuring Health A Guide to Rating
Scales and Questionnaires 3rd ed. New York:
Oxford University Press. 2006, p. 273- 93.